All treatments
Treatment
TACHIPIRINA 500 mg compresse clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
Obinutuzumab for primary membranous nephropathy: a pilot study in patients with rituximab-resistant or rituximab-dependent nephrotic syndrome and in patients intolerant to rituximab (the ORION study)
This study looks at a new drug, Obinutuzumab, for a kidney disease called primary membranous nephropathy. It's for people whose disease hasn’t responded well to a common treatment called rituximab, or if they can’t take rituximab. We want to see how well it works and if it's safe.
For: Primary Membranous NephropathyItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
A phase 2, multicenter, randomized, double blind, active controlled, parallel group study assessing the analgesic effect and safety of two doses of DFL24412 in patients with chronic low back pain compared to Ketoprofen Lysine Salt (KLS)
This study is testing different doses of a new medicine (DFL24412) for long-lasting lower back pain. Researchers want to see if it reduces pain and is safe, comparing it to a common painkiller called Ketoprofen Lysine Salt.
For: Chronic low back painItaly · Spain